Chronimed Schedules Third Quarter Financial Results Release and Conference Call.Business Editors & Health/Medical Writers MINNEAPOLIS--(BUSINESS WIRE)--April 24, 2002 Chronimed Inc. (Nasdaq:CHMD CHMD Change Mode Command ), will release financial results for its third quarter ended March 29, 2002 after market close on Tuesday, April 30, 2002. Chronimed will host a conference call at 9:00 AM CDT CDT abbr. Central Daylight Time CDT Central Daylight Time CDT n abbr (US) (= Central Daylight Time) → hora de verano del centro; (BRIT on Wednesday, May 1, 2002 featuring remarks by chairman and chief executive officer, Henry Blissenbach and chief financial officer, Greg Keane. A live broadcast of the conference call can be heard by dialing 212-896-6010 or via the Company's web site at www.chronimed.com. A replay of the call will be made available starting at 11:00 AM CDT on May 1, 2002 through 11:00 AM CDT on May 2, 2002 and can be accessed by dialing 800-633-8284 or 858-812-6440 access number 20552994. A replay of the conference call will also be made available at www.chronimed.com. About Chronimed Chronimed Inc. is a disease-focused drug distribution company serving the prescription drug prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug, needs of people with chronic health conditions. The Company distributes pharmaceuticals and provides specialized patient management services nationwide for people with chronic conditions such as HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome , organ transplant organ transplant: see transplantation, medical. and diseases treated with biotech injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. medications. Chronimed works directly with patients, providers, payors, manufacturers and wholesalers to improve clinical and cost-of-care outcomes. Chronimed's web site address is www.chronimed.com. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion